Detalhe da pesquisa
1.
The prognostic and potentially immunomodulatory role of cartilage oligomeric matrix protein in patients with gastric and esophageal adenocarcinoma.
Cancer Immunol Immunother
; 73(5): 93, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38563861
2.
CSMD1 regulates brain complement activity and circuit development.
Brain Behav Immun
; 119: 317-332, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38552925
3.
Extracellular matrix: paving the way to the newest trends in atherosclerosis.
Curr Opin Lipidol
; 32(5): 277-285, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34320563
4.
Synthesis and antiproliferative activity of two diastereomeric lignan amides serving as dimeric caffeic acid-l-DOPA hybrids.
Bioorg Chem
; 66: 132-44, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27155809
5.
Atherosclerotic plaque features relevant to rupture-risk detected by clinical photon-counting CT ex vivo: a proof-of-concept study.
Eur Radiol Exp
; 8(1): 14, 2024 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38286959
6.
Tumor suppressor role of the complement inhibitor CSMD1 and its role in TNF-induced neuroinflammation in gliomas.
J Exp Clin Cancer Res
; 43(1): 98, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38561856
7.
Evaluation of Glycosaminoglycans Biological Age in Cells and Tissues.
Methods Mol Biol
; 2619: 91-98, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36662464
8.
Expression of Cartilage Oligomeric Matrix Protein in colorectal cancer is an adverse prognostic factor and correlates negatively with infiltrating immune cells and PD-L1 expression.
Front Immunol
; 14: 1167659, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37207219
9.
Expression of cartilage oligomeric matrix protein in periampullary adenocarcinoma is associated with pancreatobiliary-type morphology, higher levels of fibrosis and immune cell exclusion.
Oncoimmunology
; 11(1): 2111906, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35990519
10.
Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy.
J Exp Clin Cancer Res
; 40(1): 258, 2021 Aug 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34404439
11.
Cartilage Oligomeric Matrix Protein initiates cancer stem cells through activation of Jagged1-Notch3 signaling.
Matrix Biol
; 81: 107-121, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30502484
12.
Novel potential inhibitors of complement system and their roles in complement regulation and beyond.
Mol Immunol
; 102: 73-83, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30217334
13.
Correction: Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy.
J Exp Clin Cancer Res
; 42(1): 135, 2023 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37248519
14.
Correction: Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer.
Oncotarget
; 14: 481-482, 2023 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37204255
15.
Extracellular matrix structure.
Adv Drug Deliv Rev
; 97: 4-27, 2016 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26562801
16.
Biochemical and toxicological evaluation of nano-heparins in cell functional properties, proteasome activation and expression of key matrix molecules.
Toxicol Lett
; 240(1): 32-42, 2016 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26476401
17.
Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer.
Oncotarget
; 7(47): 76920-76933, 2016 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27764775
18.
Emerging aspects of nanotoxicology in health and disease: From agriculture and food sector to cancer therapeutics.
Food Chem Toxicol
; 91: 42-57, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26969113